Alagille syndrome is a multisystem, highly variable, autosomal dominant disorder, which can be triggered by spontaneous mutation. This disease primarily affects the liver (chronic cholestasis), heart (most often peripheral pulmonary stenosis), eyes (posterior embryotoxon), face (characteristic features), and skeleton (butterfly vertebrae). The paper presents the clinical case of prolonged jaundice with an increased liver enzymes in infant and no final diagnosis for a long time.
INTRODUCTION

CASE STUDY
Alagille syndrome (ICD-10:Q44.7; ORPHA:52) -autosomal dominant disorder, which is variably characterized by . We would like to provide a clinical case and share our clinical experience in AGS diagnosis and treatment.
---------------- The child is on adapted formula feeding from birth and was not vaccinated (except vaccinations rendered at birth).
Most recent clinical history and findings:
On physical examination his weight was measured to be 8 kg (3 percentile), he did not have fever, was neither able to sit, nor to walk, had no teeth, had a prominent forehead and deep-set eyes. There was maculo-papular itching rash on his skin. Neurological examination did not reveal any abnormalities. Skeletomuscular and ophthalmological findings were within normal range. Throat and oral mucosa had no pathological signs. Lymph nodes were not enlarged.
Heart auscultation revealed murmur. Respiratory status was normal. Abdomen was soft with normal bowel sounds.
Liver was enlarged by 2 centimeters. He was not found to diagnostic purposes [4] . The biopsy results of our patient neither confirmed nor denied the diagnosis, since the sample did not include the biliary tract, which is an important step in diagnosing Alagille syndrome.
Medical treatment:
Cholestasis in AGS is commonly profound and manifests clinically with pruritus. Cholestasis typically worsens until school age and then, in some children, it improves or stabilizes. Pruritus observed in AGS is among the most severe of any chronic liver diseases. Unfortunately, there are no known radiological or genetic markers that can predict which children will have progression of their liver disease and in which children it will improve. Pruritus often disturbs sleep, daily activities, and cognitive development [5] .
Bile flow may be stimulated by choleretics, and ursodeoxycholic acid, as the most commonly used agent (10-20 mg/kg/day, divided in 2 doses). Bile acid-binding resins, such as cholestyramine, 240 mg/kg/day, divided into 3 doses with maximum dose of 8 g/day, are often effective but not palatable. One of these two medications is a first line therapy for AGS [2] .
Patient treatment:
Vitamin D and Vitamin A were no longer required, ursodeoxycholic acid was administered at the same dosage and 4 g/day of Cholestyramine as a bile salt-binding agent and emollients to keep the skin hydrated were additionally introduced into the therapy. As a result, this modified treatment improved pruritus and appetite.
year follow-up (April 2016).
 The child turned 2.5 years.
 His appetite was good.
 He weighed 10 kg (3 percentile).
 The patient continued to receive ursodeoxycholic acid, and cholestyramine dosage was increased to 8 mg/day.
 Pruritus still persisted.
Further monitoring of this disease is determined by the degree of cholestasis and possible complications. It is also recommended to check fat-soluble vitamin levels twice a year. According to the textbook, the process might stabilize within the period when the child is 4-10 years old; however in 30 % of cases there is a need for liver transplant [4, 5] .
